[1]
“Comparative efficacy and safety of Tirzepatide versus Semaglutide for obesity management”, J. Assoc. Clin. Endocrinol. Diabetol. Bangladesh, vol. 4, no. 20, p. S70, Oct. 2025, doi: 10.3329/jacedb.v4i20.84989.